CBD Life Sciences Inc. (OTCMKTS:CBDL) Sees Large Growth in Short Interest

CBD Life Sciences Inc. (OTCMKTS:CBDLGet Free Report) saw a significant growth in short interest in the month of October. As of October 15th, there was short interest totalling 202,600 shares, a growth of 21.6% from the September 30th total of 166,600 shares. Based on an average daily trading volume, of 67,047,700 shares, the short-interest ratio is presently 0.0 days.

CBD Life Sciences Price Performance

Shares of CBD Life Sciences stock opened at $0.00 on Tuesday. CBD Life Sciences has a 52-week low of $0.00 and a 52-week high of $0.03.

About CBD Life Sciences

(Get Free Report)

CBD Life Sciences Inc engages in the development and marketing a line of cannabidiol based organic products. Its cannabidiol based organic products include hemp drops, massage oils, recovery pain relief creams, anxiety and sleep solutions supplements, edibles, and a line of pet products. The company is based in Scottsdale, Arizona.

Recommended Stories

Receive News & Ratings for CBD Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CBD Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.